These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22024702)

  • 1. Genetic variation in complement regulators and susceptibility to age-related macular degeneration.
    Cipriani V; Matharu BK; Khan JC; Shahid H; Stanton CM; Hayward C; Wright AF; Bunce C; Clayton DG; Moore AT; Yates JR
    Immunobiology; 2012 Feb; 217(2):158-61. PubMed ID: 22024702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of DNA-variants in the properdin gene (CFP) in age-related macular degeneration (AMD).
    Seitsonen S; Onkamo P; Torniainen S; Ihalainen M; Immonen I; Meri S; Järvelä I
    Mol Immunol; 2010 Mar; 47(6):1334-6. PubMed ID: 20122735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration.
    Ebrahimi KB; Fijalkowski N; Cano M; Handa JT
    J Pathol; 2013 Apr; 229(5):729-42. PubMed ID: 23097248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population.
    Wu L; Tao Q; Chen W; Wang Z; Song Y; Sheng S; Li P; Zhou J
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):170-4. PubMed ID: 23233260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of complement regulatory proteins in the human retina.
    Fett AL; Hermann MM; Muether PS; Kirchhof B; Fauser S
    Histol Histopathol; 2012 Mar; 27(3):357-64. PubMed ID: 22237713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study.
    Farwick A; Dasch B; Weber BH; Pauleikhoff D; Stoll M; Hense HW
    Eye (Lond); 2009 Dec; 23(12):2238-44. PubMed ID: 19169232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans.
    Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I
    Mol Vis; 2014; 20():105-16. PubMed ID: 24453474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of CFD polymorphisms with advanced age-related macular degeneration.
    Zeng J; Chen Y; Tong Z; Zhou X; Zhao C; Wang K; Hughes G; Kasuga D; Bedell M; Lee C; Ferreyra H; Kozak I; Haw W; Guan J; Shaw R; Stevenson W; Weishaar PD; Nelson MH; Tang L; Zhang K
    Mol Vis; 2010 Nov; 16():2273-8. PubMed ID: 21139680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilocus analysis of age-related macular degeneration.
    Bergeron-Sawitzke J; Gold B; Olsh A; Schlotterbeck S; Lemon K; Visvanathan K; Allikmets R; Dean M
    Eur J Hum Genet; 2009 Sep; 17(9):1190-9. PubMed ID: 19259132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration.
    Hageman GS; Gehrs K; Lejnine S; Bansal AT; Deangelis MM; Guymer RH; Baird PN; Allikmets R; Deciu C; Oeth P; Perlee LT
    Hum Genomics; 2011 Jul; 5(5):420-40. PubMed ID: 21807600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C3 variant and the risk of age-related macular degeneration.
    Yates JR; Sepp T; Matharu BK; Khan JC; Thurlby DA; Shahid H; Clayton DG; Hayward C; Morgan J; Wright AF; Armbrecht AM; Dhillon B; Deary IJ; Redmond E; Bird AC; Moore AT;
    N Engl J Med; 2007 Aug; 357(6):553-61. PubMed ID: 17634448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.
    de Breuk A; Acar IE; Kersten E; Schijvenaars MMVAP; Colijn JM; Haer-Wigman L; Bakker B; de Jong S; Meester-Smoor MA; Verzijden T; Missotten TOAR; Monés J; Biarnés M; Pauleikhoff D; Hense HW; Silva R; Nunes S; Melo JB; Fauser S; Hoyng CB; Ueffing M; Coenen MJH; Klaver CCW; den Hollander AI;
    Ophthalmology; 2021 Nov; 128(11):1604-1617. PubMed ID: 32717343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation.
    Proitsi P; Lupton MK; Dudbridge F; Tsolaki M; Hamilton G; Daniilidou M; Pritchard M; Lord K; Martin BM; Johnson J; Craig D; Todd S; McGuinness B; Hollingworth P; Harold D; Kloszewska I; Soininen H; Mecocci P; Velas B; Gill M; Lawlor B; Rubinsztein DC; Brayne C; Passmore PA; Williams J; Lovestone S; Powell JF
    Neurobiol Aging; 2012 Aug; 33(8):1843.e9-17. PubMed ID: 22300950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement factor B polymorphism 32W protects against age-related macular degeneration.
    Hughes AE; Mullan GM; Bradley DT
    Mol Vis; 2011 Apr; 17():983-8. PubMed ID: 21541267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 21-bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course.
    Bos JW; Groen EJN; Otten HG; Budding K; van Eijk RPA; Curial C; Kardol-Hoefnagel T; Goedee HS; van den Berg LH; van der Pol WL
    J Peripher Nerv Syst; 2024 Jun; 29(2):193-201. PubMed ID: 38528725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic complement activation in age-related macular degeneration.
    Scholl HP; Charbel Issa P; Walier M; Janzer S; Pollok-Kopp B; Börncke F; Fritsche LG; Chong NV; Fimmers R; Wienker T; Holz FG; Weber BH; Oppermann M
    PLoS One; 2008 Jul; 3(7):e2593. PubMed ID: 18596911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.